Skip to main content

Charles River Laboratories total debt

  • CRL · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$337.97−0.83%Close 13 Nov 2026 · Market value $16.04B

Charles River Laboratories's total debt was $2.63 billion for fiscal year 2025 (the twelve months to 27 Dec 2025), down 5.4% from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 26 Sep 2026) it was $2.85 billion, up 8.5% from a year earlier.

From Charles River Laboratories's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026.

Fiscal 2025
$2.63B
−5.4%
Q3 FY2026
$2.85B
+8.5% on a year
Growth over 9 years
+9.0%
a year, FY 2016–FY 2025

Total debt by fiscal year

$1.21BFY 2016$1.12BFY 2017−7.6%$1.65BFY 2018+47.7%$2.02BFY 2019+22.2%$2.16BFY 2020+6.7%$2.95BFY 2021+36.8%$3.15BFY 2022+6.6%$3.12BFY 2023−0.7%$2.78BFY 2024−11.1%$2.63BFY 2025−5.4%

Change on the year before, under each year. From FY 2016 to FY 2025, Charles River Laboratories's total debt went from $1.21 billion to $2.63 billion, a compound annual change of +9.0%; the highest was $3.15 billion in FY 2022.

Charles River Laboratories total debt, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Total debt$1.21B$1.12B$1.65B$2.02B$2.16B$2.95B$3.15B$3.12B$2.78B$2.63B
Period end31 Dec 201630 Dec 201729 Dec 201828 Dec 201926 Dec 202025 Dec 202131 Dec 202230 Dec 202328 Dec 202427 Dec 2025

Total debt by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

Charles River Laboratories total debt, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Total debt$2.78B$2.99B$2.79B$2.63B$2.63B$3.06B$3.03B$2.85B
Period end28 Dec 202429 Mar 202528 Jun 202527 Sep 202527 Dec 202528 Mar 202627 Jun 202626 Sep 2026

How total debt is measured

Total debt is the company's borrowings at the end of the period: short-term and long-term debt, including the current portion of long-term debt and finance leases. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

Charles River Laboratories's other figures

Total debt of comparable companies

Everything on CRL, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.